Yeongjin Pharm Signs Supply Contract Worth 12.2 Billion KRW

[Asia Economy Reporter Eunmo Koo] Youngjin Pharm announced on the 7th that it has signed a supply contract for cephalosporin antibiotic finished pharmaceutical products worth 12,240,870,000 KRW with the Japanese company MYLAN SEIYAKU LTD. The company explained, "This contract is not a new contract, but a modification contract extending the contract period to 3 years for the existing reservation concluded on October 10, 2014." The contract period is from the 10th of this month to October 9, 2023.

This content was produced with the assistance of AI translation services.